Company / Revenue per Share
Krystal Biotech, Inc. Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$13.51
FY2025
5-year range
$0.00 / $13.51
FY2021-FY2025
Trend
+31.4%
vs FY2024
Sector context
#38 of 154
Health Care
What the data says
Krystal Biotech, Inc.'s revenue per share of $13.51 is higher than 75% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $13.51 in FY2025.
Based on SEC 10-K filings.
13.51 in FY2025. Top quartile in the Health Care sector.
Improved from $1.97 to $13.51 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 154This company $13.51 Sector average $15.09
▼
-10.4% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 31.4% year-over-year.
- Ranks #38 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.51 | +31.4% |
| FY2024 | $10.29 | +422.8% |
| FY2023 | $1.97 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026